Financial reports
10-K/A
2021 FY
Annual report (amended)
10 Mar 22
10-K
2021 FY
Annual report
23 Feb 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2019 FY
Annual report
23 Feb 21
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
27 Feb 20
Current reports
8-K
Completion of Acquisition or Disposition of Assets
11 Mar 22
8-K
Other Events
10 Mar 22
8-K
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
23 Feb 22
8-K
Other Events
7 Feb 22
8-K
Submission of Matters to a Vote of Security Holders
2 Feb 22
8-K
Other Events
7 Jan 22
8-K
Entry into a Material Definitive Agreement
13 Dec 21
8-K
Arena Reports Third Quarter Financial Results and Key Program Updates
4 Nov 21
8-K
Arena Reports Second Quarter Financial Results and Key Program Updates
5 Aug 21
8-K
Departure of Directors or Certain Officers
17 Jun 21
Registration and prospectus
15-12G
Securities registration termination
21 Mar 22
25-NSE
Exchange delisting
11 Mar 22
POSASR
Automatic shelf registration (post-effective amendment)
11 Mar 22
POS AM
Prospectus update (post-effective amendment)
11 Mar 22
POS AM
Prospectus update (post-effective amendment)
11 Mar 22
POS AM
Prospectus update (post-effective amendment)
11 Mar 22
POS AM
Prospectus update (post-effective amendment)
11 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Jan 22
DEFA14A
Additional proxy soliciting materials
21 Jan 22
DEFA14A
Additional proxy soliciting materials
7 Jan 22
DEFM14A
Proxy related to merger
3 Jan 22
PREM14A
Preliminary proxy related to merger
23 Dec 21
DEFA14A
Additional proxy soliciting materials
15 Dec 21
DEFA14A
Additional proxy soliciting materials
14 Dec 21
DEFA14A
Additional proxy soliciting materials
13 Dec 21
DEFA14A
Additional proxy soliciting materials
13 Dec 21
DEFA14A
Additional proxy soliciting materials
27 Apr 21
Other
EFFECT
Notice of effectiveness
16 Mar 22
EFFECT
Notice of effectiveness
16 Mar 22
EFFECT
Notice of effectiveness
16 Mar 22
EFFECT
Notice of effectiveness
16 Mar 22
CT ORDER
Confidential treatment order
20 Mar 19
UPLOAD
Letter from SEC
29 Aug 18
CORRESP
Correspondence with SEC
28 Aug 18
UPLOAD
Letter from SEC
26 Jul 18
CT ORDER
Confidential treatment order
8 May 17
UPLOAD
Letter from SEC
8 Sep 16
Ownership
4
Longboard Pharmaceuticals, Inc.
29 Jan 24
4
Tina Susan Nova
11 Mar 22
4
OLIVER FETZER
11 Mar 22
4
KIERAN GALLAHUE
11 Mar 22
4
Katharine Knobil
11 Mar 22
4
Jennifer Jarrett
11 Mar 22
4
GARRY ARTHUR NEIL
11 Mar 22
4
Steven J Schoch
11 Mar 22
4
Jayson Donald Alexander Dallas
11 Mar 22
4
Nawal Ouzren
11 Mar 22